The FLI1 gene helps switch other genes on and off, especially in cells that form platelets, blood vessels, and some immune cells. This gene plays an important role in helping your body make platelets that stop bleeding after a cut. If the FLI1 gene does not work properly, some people have low platelet counts, easy bruising, nosebleeds, or other bleeding problems. Acquired changes involving the FLI1 gene can also be part of some cancers, including Ewing sarcoma.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or managing activities throughout the body. Some genes hold the directions for producing proteins, which are the parts of cells that do much of the work. Other genes mainly regulate when certain activities happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
FLI1Gene function
What if the gene works
Your cells use the FLI1 gene to control when other genes switch on in developing blood cells and blood vessel lining. It helps platelets form normally and supports healthy vessel function.
Risk
What if the gene does not work
Variants in the FLI1 gene most often affect platelet formation and function, which can cause easy bruising, nosebleeds, or low platelet counts; effects may range from mild bleeding tendencies to more marked platelet problems, depending on the variant.
Treatment
What does that mean for your treatment
No FLI1-specific treatment or drug choice is currently established for people with a pathogenic or loss-of-function variant in the FLI1 gene. The FLI1 gene is being studied as a cancer biomarker and drug target, especially in Ewing sarcoma when FLI1 is fused to another gene, but that research does not guide treatment for inherited FLI1 loss-of-function variants.
Conditions associated with FLI1
Gene function
What if the gene works
When the FLI1 gene is working normally, it helps certain cells follow the right instructions at the right time. This matters most in cells that line blood vessels and in bone marrow cells that make platelets. Understanding FLI1 gene function helps show how these cells grow, organize themselves, and handle everyday tasks.
The FLI1 gene makes a protein that binds DNA and acts like a switch for other genes. This helps certain cells turn the right instructions on or off as they grow and do their usual work.
In cells that form the inner lining of blood vessels, the FLI1 gene helps coordinate growth, shape, and attachment. This supports stable vessel walls and smooth everyday blood flow.
In the bone marrow, the FLI1 gene helps platelet-making cells mature and release platelets into the blood. Platelets are tiny cell fragments that help your body form a clot after a cut or nosebleed.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change the function of a gene more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the FLI1 gene can lower the amount of FLI1 made, change its shape, or weaken its ability to bind DNA and switch other genes on in developing blood cells. How FLI1 gene variants affect platelet production often depends on severity: milder variants may partly reduce this control, while more severe variants that stop the gene from working can largely abolish it. In inherited platelet conditions, greater functional loss is often linked to earlier or more noticeable bleeding features.
How variants are linked to conditions
Pathogenic variants in the FLI1 gene are linked mainly to inherited thrombocytopenia and bleeding. People with this diagnosis often have low platelet counts, easy bruising, nosebleeds, or heavier menstrual bleeding. Deletions that include the FLI1 gene are also a recognized part of Jacobsen syndrome and are strongly associated with Paris-Trousseau thrombocytopenia.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely seen in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the FLI1 gene. In families with an inherited FLI1 change, the main issue is the gene change itself, while symptoms can still vary from one person to another. Anyone with concerns about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of FLI1 variants
For families looking into how FLI1 gene variants are inherited, the best established pattern is autosomal dominant. This means a person with a disease-causing variant in one copy of the FLI1 gene can pass it to a child, and each pregnancy carries a 50% chance of inheriting that variant. Sons and daughters are affected equally, and either parent can pass the variant on.
What does my FLI1 result mean for my family?
For FLI1, a disease-causing result is most often linked to a dominant pattern, which means close relatives such as parents, brothers, sisters, and children may also carry the same change. Some family members may have easy bruising, nosebleeds, heavy periods, or low platelets, while others have milder signs. Because of that, relatives may also want to learn whether the result applies to them.
Genetic information
Genetic testing
How you find out about variants
For people being evaluated for inherited platelet or bleeding conditions, genetic testing for FLI1 variants usually examines DNA from a blood sample or saliva. Labs use sequencing, and sometimes checks for missing or extra pieces of the gene, to find changes that may help explain symptoms or clarify whether a variant runs in a family.
When should I consider getting a genetic test?
Consider testing for changes in the FLI1 gene if there is lifelong low platelet counts, easy bruising, or unusual bleeding, such as frequent nosebleeds, heavy periods, or bleeding after dental work, especially when it runs in the family. Testing may also be part of an evaluation when a child has signs of Jacobsen syndrome, a condition caused by missing genetic material.
A genetic result is only one part of your health story
Genetic findings can offer useful insight, but how much they reveal depends on the condition and on the kind of variant involved. How the body works over time is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same treatment may work well for one person, work less well for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way a person responds to medication. It studies gene drug relationships to help explain why the same treatment may work differently in different people. With many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment choices that are better informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the FLI1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so any concerns about medicines, side effects, or your overall health are best discussed with your doctor. If you have unusual bruising, frequent nosebleeds, or bleeding that is hard to stop, seek medical advice promptly.
History
The FLI1 gene entered medical research through leukemia studies in mice, where scientists traced a virus insertion site and gave the gene its name, Friend leukemia virus integration 1. First described in the scientific literature as part of early genetics, it soon became important beyond virus research. In the 1990s, a major turning point came when researchers found that the FLI1 gene is involved in the characteristic gene fusion seen in many cases of Ewing sarcoma, a cancer of bone or soft tissue. That discovery helped make FLI1 part of a broader shift toward understanding cancers through their genetic changes. From these first observations, research expanded steadily. Today, the FLI1 gene is remembered as one of the genes that helped shape modern cancer genetics.